Lisa Carey, MD
Enriched profileL. Richardson and Marilyn Jacobs Preyer Distinguished Professor for Breast Cancer Research; Deputy Director for Clinical Sciences, UNC Lineberger Comprehensive Cancer Center · University of North Carolina at Chapel Hill
Lisa Carey is L. Richardson and Marilyn Jacobs Preyer Distinguished Professor for Breast Cancer Research; Deputy Director for Clinical Sciences, UNC Lineberger Comprehensive Cancer Center at University of North Carolina at Chapel Hill. OpenAlex indexes 987 publications with 54,947 citations (h-index 105); ClinicalTrials.gov lists 15 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Hematology / Oncology profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Lisa Carey, MD, is L. Richardson and Marilyn Jacobs Preyer Distinguished Professor for Breast Cancer Research at University of North Carolina at Chapel Hill, School of Medicine / UNC Lineberger Comprehensive Cancer Center. The public record shows 987 publications with 54,947 citations (h-index 105), centered on Breast Cancer Treatment Studies, Advanced Breast Cancer Therapies, HER2/EGFR in Cancer Research. It also documents an investigator role on 15 registered clinical trials, industry payments reported by 9 companies, 8 NIH-funded awards (2000–2026).
- Most recent indexed publication: 2026 · Molecular cancer therapeutics
- Top research focus: Breast Cancer Treatment Studies
- 15 registered trials on ClinicalTrials.gov
- Open Payments reporting from 9 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 67 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 365.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 15 registered studies on ClinicalTrials.gov. The most recent:
- Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies
Sponsor: UNC Lineberger Comprehensive Cancer Center
- Efficacy and Safety of Intravenous Efzofitimod in Patients With Pulmonary Sarcoidosis
Sponsor: aTyr Pharma, Inc.
Industry payments
Updated 27 Aug 2026
9 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year20253 payments
- PFIZER INC.Program year20255 payments
- Eli Lilly and CompanyProgram year20251 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
83.2%Aromatase Inhibitor62.1%Letrozole77%Anastrozole23%Part D<11 patientsKinase inhibitor12.1%Kisqali54%Ibrance46%Part D<11 patientsNervous system
11.2%SNRI5.6%Duloxetine Hcl100%Part D<11 patientsGabapentinoids5.6%Gabapentin100%Part D<11 patientsMetabolism & gastrointestinal
5.6%Serotonin-3 Receptor Antagonist5.6%Ondansetron Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
8 NIH research awards on record, funded 2000–2026 per NIH RePORTER. The latest:
- Elucidating the molecular mechanisms of metastasis organ tropism
Univ of North Carolina Chapel Hill
FY2026$639,718U01CA289839 - Optimizing prognostic and predictive algorithms using residual disease (RD) genomic biomarkers in HER2+ and TNBC
Univ of North Carolina Chapel Hill
FY2026$590,870R01CA229409
Congress activity
Updated 27 Aug 2026
176 congress contributions (2004–2026) across AACR, ASCO, ASTRO, ESMO, SABCS per OpenAlex. The most recent:
- Abstract 78: Snord67 promotes breast cancer metastasis through U6-mediated alternative splicing
AACR Annual Meeting
AACR2025Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Kinase Plasticity with Vandetanib Treatment Enhances Sensitivity to Tamoxifen in Estrogen Receptor Positive Breast Cancer.
Molecular cancer therapeutics
Article2026 - Identifying Locally Recurrent Versus Second Primary Breast Cancer: Genomic Versus Clinical Criteria from Carolina Breast Cancer Study Phase III.
Cancer epidemiology, biomarkers & prevention
Clinical Trial2026
Most-cited works
by citation count (OpenAlex)- 01Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer StudyArticle3,845 citations2006
- 02The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer SubtypesArticle2,122 citations2007
- 03Sacituzumab Govitecan in Metastatic Triple-Negative Breast CancerArticle1,589 citations2021
- 04Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline UpdateArticle1,534 citations2020
- 05The molecular portraits of breast tumors are conserved across microarray platformsArticle1,472 citations2006
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
opmed.doximity.com/authors/lisa-a-carey-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →opmed.doximity.com ↗ - Doximity
doximity.com/pub/lisa-carey-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/lisa-carey-83583441
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗
Mentions by others
where others cite or feature them- Facebook
facebook.com/unchealthcare/posts/dr-lisa-carey-of-unc-lineberger-comprehensive-cancer-center-is-the-only-breast-c/3767170573295080
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com ↗ - Facebook
facebook.com/unchealthcare/videos/unc-lineberger-cancer-researcher-dr-lisa-carey-on-wral-tv/3066522313422325
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com ↗ - Facebook
facebook.com/unclineberger/posts/unc-linebergers-lisa-carey-md-scm-fasco-will-lead-the-development-of-a-next-gene/1331063065695659
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗
- BA
Wellesley College
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗ - MD
Johns Hopkins University School of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗ - ScM (MS)
Johns Hopkins Bloomberg School of Public Health
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗ - Residency and fellowship
Johns Hopkins Hospital (internal medicine / medical oncology)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →unclineberger.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →unclineberger.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗
Media & interviews
press, podcasts and appearances- Chair's Corner Podcast (UNC Department of Medicine)
Dr. Ron Falk interviews Carey on breast cancer research and care
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu ↗ - "Surviving Breast Cancer with Dr. Lisa Carey & Ms. Barbara Martin"
Your Health Radio (UNC Health Care)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →yourhealthradio.web.unc.edu ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →player.vimeo.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Robert Sandler, MD
University of North Carolina at Chapel Hill
Diana Perkins, MD
University of North Carolina at Chapel Hill
Hyman Muss, MD
University of North Carolina at Chapel Hill
Norman Sharpless, MD
University of North Carolina at Chapel Hill